SIM
ALXA

Spark Investment Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Spark Investment Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,800
Closed -$80K – 877
2014
Q3 		$80K Buy
33,800
+22,900
+210% +$87.4K 0.01% 609
2014
Q2 		$49K Hold
10,900
– – 0.01% 597
2014
Q1 		$48K Buy
+10,900
New +$55.9K 0.01% 642

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spark Investment Management's ALXA Position: Q4 2014 in Review

Spark Investment Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2014, closing a stake of 33,800 shares — an estimated $80K sold.

Spark Investment Management first reported a position in ALXA in Q1 2014 and held it in 3 quarters. The position peaked at $80K in Q3 2014. 31 funds tracked by Wall St. Rank hold ALXA as of Q4 2014.

  • Spark Investment Management reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Spark Investment Management sold 33,800 Alexza Pharmaceuticals Inc shares in Q4 2014, an estimated $80K.
  • Spark Investment Management first reported a position in Alexza Pharmaceuticals Inc in Q1 2014 and held it in 3 quarters.
  • Spark Investment Management's Alexza Pharmaceuticals Inc position peaked at $80K in Q3 2014.
  • 31 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2014.

Based on Spark Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.